169 related articles for article (PubMed ID: 30680766)
1. Cutaneous involvement as the first manifestation of T-lymphoblastic lymphoma and review of the literature.
Montes-Torres A; Llamas-Velasco M; Capusan TM; Aguado B; Adrados M
J Cutan Pathol; 2019 May; 46(5):372-375. PubMed ID: 30680766
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
3. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
[TBL] [Abstract][Full Text] [Related]
4. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
5. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous lymphoblastic lymphoma in children: report of six cases with precursor B-cell lineage.
Kahwash SB; Qualman SJ
Pediatr Dev Pathol; 2002; 5(1):45-53. PubMed ID: 11815868
[TBL] [Abstract][Full Text] [Related]
7. A Case of Cutaneous Involvement in T Lymphoblastic Lymphoma Leukemia.
Zhang L; Zeng Y; Cheng N; Liu X; Li X; Long B; Lin D
Clin Lab; 2017 Sep; 63(9):1497-1500. PubMed ID: 28879704
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous precursor B-cell lymphoblastic lymphoma in 2 adult patients: clinicopathologic and molecular cytogenetic studies with a review of the literature.
Shafer D; Wu H; Al-Saleem T; Reddy K; Borghaei H; Lessin S; Smith M
Arch Dermatol; 2008 Sep; 144(9):1155-62. PubMed ID: 18794461
[TBL] [Abstract][Full Text] [Related]
9. [MIC2 (CD99) as a diagnostic marker for TdT-negative B lymphoblastic lymphoma].
Ikeda N; Imao T; Hisano Y; Kamao T; Uno M; Mizushima T
Rinsho Ketsueki; 2023; 64(2):130-132. PubMed ID: 36990733
[TBL] [Abstract][Full Text] [Related]
10. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
11. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877
[TBL] [Abstract][Full Text] [Related]
12. Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
Vezzoli P; Novara F; Fanoni D; Gambini D; Balice Y; Venegoni L; Paulli M; Crosti C; Berti E
Leuk Lymphoma; 2012 Oct; 53(10):1978-87. PubMed ID: 21879810
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous B-cell lymphoblastic lymphoma in children: a rare diagnosis.
Boccara O; Laloum-Grynberg E; Jeudy G; Aubriot-Lorton MH; Vabres P; de Prost Y; Pacquement H; Brousse N; Fraitag S; Bodemer C
J Am Acad Dermatol; 2012 Jan; 66(1):51-7. PubMed ID: 21745698
[TBL] [Abstract][Full Text] [Related]
14. CD99 in malignant hematopoiesis.
Ali A; Vaikari VP; Alachkar H
Exp Hematol; 2022 Feb; 106():40-46. PubMed ID: 34920053
[TBL] [Abstract][Full Text] [Related]
15. Lymphoblastic lymphoma of the pre-B phenotype with cutaneous presentation.
Schmitt IM; Manente L; Di Matteo A; Felici F; Giangiacomi M; Chimenti S
Dermatology; 1997; 195(3):289-92. PubMed ID: 9407185
[TBL] [Abstract][Full Text] [Related]
16. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
Soslow RA; Baergen RN; Warnke RA
Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
[TBL] [Abstract][Full Text] [Related]
17. Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma.
Satoh T; Kayano H; Kohri M; Tanae K; Asou C; Takahashi N; Tsukasaki K; Yasuda M
J Clin Exp Hematop; 2023; 63(4):257-261. PubMed ID: 38148016
[TBL] [Abstract][Full Text] [Related]
18. T-cell lymphoblastic lymphoma presenting with a breast mass.
Yumuk PF; Aydiner A; Topuz E; Cabioglu N; Dogan O
Leuk Lymphoma; 2004 Apr; 45(4):833-6. PubMed ID: 15160967
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous B-Cell lymphoblastic lymphoma presenting with solitary scalp mass in a female child: A case report and review of the literature.
Montazer F; Motlagh AS; Dastgir R
Clin Case Rep; 2022 Nov; 10(11):e6553. PubMed ID: 36381035
[TBL] [Abstract][Full Text] [Related]
20. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
